Zynex Inc (ZYXI) 0.4300 $ZYXI Zynex Announces 2013 Year

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Zynex Inc (ZYXI) 0.4300 $ZYXI

Zynex Announces 2013 Year End Results
Marketwire - Thu Mar 27, 7:02AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today its year end 2013 financial results.

Zynex Schedules Year End 2013 Earnings Conference Call and Webcast
Marketwire - Thu Mar 20, 7:00AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host an investor webcast on Thursday, March 27, 2014 at 11:00 a.m. ET -- 9:00 a.m. MT -- to discuss the Company's year end 2013 results.

Zynex Non-Sterile Compound Pharmacy Attains Licensing in 19 States
Marketwire - Mon Mar 03, 7:01AM CST
Zynex, Inc. (OTCQB: ZYXI), a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that its subsidiary Zynex Medical, recently received its 19th state license for its non-sterile compound pharmacy.

Zynex Expands Electrotherapy Product Sales Channel
Marketwire - Tue Feb 11, 7:02AM CST
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation and neurological diagnostics announces that it signed a strategic sales and marketing agreement with Total Care Marketing, LLC to sell its primary electrotherapy device, the NexWave, through Total Care Marketing's sales organization.

Zynex Receives Roszdravnadzor (Russian Equivalent of FDA) Clearance to Market Neuromove(TM) Stroke Recovery Device and NexWave(TM) Electrotherapy Device in Russia
Marketwire - Thu Feb 06, 7:00AM CST
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation and neurological diagnosis, announced today that Russia's Federal Service on Surveillance in Healthcare (Roszdravnadzor) has granted clearance to market its NeuroMove(TM) stroke recovery device and NexWave(TM) electrotherapy device.

ZTE, JD.com Sign CNY3.5bn Agreement
SinoCast - Fri Jan 17, 4:48AM CST
ZTE Corporation January 16 signed a CNY 3.5 billion strategic cooperation agreement with JD.com, which showed that the two will jointly launch the Youth mobile phones.

Zynex Appoints Vice President of Sales for NeuroDiagnostics Division
Marketwire - Tue Jan 07, 7:00AM CST
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation, and neurological diagnosis, announced today that it has appointed James Carter as Vice President of Sales for its NeuroDiagnostics division.

Zynex Signs Distribution Agreement for China Market
Marketwire - Tue Dec 24, 7:30AM CST
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation and neurological diagnosis, announced today that it signed a five-year exclusive distribution agreement with DIH Medical Technologies Co Ltd for the distribution of its NeuroMove device in China commencing December 17, 2013. Although the agreement can be cancelled upon 60 days' notice by DIH, the minimum purchase requirements over the agreements expected five-year term would equal sales of $4.6 million. The first year's minimum commitment is $750,000.

Zynex Announces Investor Relations Initiative
Marketwire - Fri Dec 20, 8:30AM CST
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation, and neurological diagnosis, announced today that it has enabled Level 2 quote visibility for investors though the OTC Markets Group.

Zynex Announces CEO Interview With The Wall Street Analyst
Marketwire - Fri Dec 06, 7:00AM CST
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced that The Wall Street Analyst conducted an audio interview with Zynex's CEO, Thomas Sandgaard.

Zynex Introduces TENSWave Medical Device
Marketwire - Mon Nov 25, 7:00AM CST
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced the introduction of its next generation electrotherapy medical device, the TENSWave.

Zynex Medical Receives 2013 Colorado Excellence Award
Marketwire - Tue Nov 19, 7:02AM CST
Zynex, Inc. (OTCQB: ZYXI), a provider of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced today that they are the recipient of the Small Business Institute for Excellence in Commerce's (SBIEC) 2013 Colorado Excellence Award.

Zynex Ranked 15th in Revenue Growth Among Medical Device Companies
Marketwire - Mon Nov 18, 7:00AM CST
Zynex, Inc. (OTCQB: ZYXI), a provider of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced today that it has been ranked 15th in revenue growth among all medical device companies in the US and Canada on Deloitte's 2013 Technology Fast 500. The company was ranked 7th in 2012.

Zynex Announces Third Quarter 2013 Financial Results
Marketwire - Thu Nov 07, 7:00AM CST
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announces its third quarter 2013 financial results.

Global Neuromodulation Market Report 2013 - 2017
M2 - Wed Nov 06, 4:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/nfb62c/neuromodulation) has announced the addition of the "Global Neuromodulation Market Report 2013 - 2017" report to their offering. The neuromodulation devices market includes deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and others external stimulation devices such as transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation (TENS). The neuromodulation technique acts directly upon nerves or the target area where the activity of nerves is altered due to biological responses produced by electrical stimulation or drug infusion. These devices include small electrodes that are attached to the brain, the spinal cord, or peripheral nerves. These precisely placed leads are connected by means of an extension cable to a pulse generator to generate electrical stimulation. Neuromodulation can have applications in any area of the body and can treat several diseases like chronic pain, epilepsy, psychiatric disorder, movement disorder, cardiovascular disorder, genitourinary and colorectal disorder, stroke and brain injury, and gastric disorder. The main drivers for the neuromodulation market are the rising population of aged people and age-related diseases like Alzheimer's, epilepsy, spinal cord injury, and Parkinson's disease. According to the International Neuromodulation Society, about 40 million to 50 million patients worldwide suffer from epilepsy, and 1.5 million people currently (2012) suffer from Parkinson disease in the U.S. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 3.1 Introduction 3.2 Market Segmentation 3.3 Market Dynamics 3.4 Restraints 3.5 Market Share Analysis 4 Global Neuromodulation Market (Internal & External) 5 Geographic Analysis 5.1 Introduction 5.2 North America 5.3 Europe 5.4 Asia 5.5 Rest Of The World 6 Competitive Landscape 6.1 Introduction 6.2 Agreements, Partnerships, Collaborations, Contracts & Joint Ventures 6.3 New Product Launch 6.4 Expansion 6.5 Other Developments 6.6 Approvals 7 Company Profiles Companies Mentioned - Anm Adaptive Neuromodulation Gmbh - Biocontrol Medical, Ltd. - Boston Scientific Corporation - Cerbomed Gmbh - Cyberonics, Inc. - Endostim, Inc. - Enteromedics, Inc. - The Magstim Company Limited - Medtronic, Inc. - Neuronetics, Inc. - Neuropace, Inc. - Neurosigma, Inc. - Nevro Corporation - Rs Medical - Spinal Modulation, Inc. - St. Jude Medical - Synapse Biomedical, Inc. - Uroplasty, Inc. - Zynex, Inc. For more information visit http://www.researchandmarkets.com/research/nf...modulation

Zynex Schedules Third Quarter 2013 Earnings Conference Call and Webcast
Marketwire - Thu Oct 31, 7:00AM CDT
Zynex, Inc. (OTCQB: ZYXI), a provider of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced today that it will host an investor webcast, Thursday, November 7, 2013 at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time to discuss the Company's third quarter 2013 results.

Zynex Receives SFDA Clearance to Market Neuromove(TM) Stroke Recovery Device in China
Marketwire - Thu Oct 24, 7:01AM CDT
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced today that China's State Food and Drug Administration (SFDA) has granted clearance to market its NeuroMove(TM) stroke recovery device.

Zynex Announces Second Quarter 2013 Financial Results
Marketwire - Thu Aug 08, 7:00AM CDT
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announces its second quarter 2013 financial results.

Zynex Schedules Second Quarter 2013 Earnings Conference Call and Webcast
Marketwire - Thu Aug 01, 7:00AM CDT
Zynex, Inc. (OTCQB: ZYXI), a provider of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced today that it will host an investor webcast, Thursday, August 8, 2013 at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time to discuss the Company's second quarter 2013 results.

Zynex Signs Strategic Agreement With Advanced Brain Monitoring, Expands Presence in Sleep Diagnostic Market
Marketwire - Mon Jul 22, 7:00AM CDT
Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnostics and cardiac monitoring, announces that it signed a strategic sales, marketing and distribution agreement with California based Advanced Brain Monitoring.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 81

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 195

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 216

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 8

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 13

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 81

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 25

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 15

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 138

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Insights on Paragon 28, Inc. Class Action Lawsuit

Updated Category News Views 106

Understanding the Paragon 28 Class Action Lawsuit Recently, investors in Paragon 28, Inc. have been alerted about a significant class action lawsuit involving the company's financial disclosures. The litigation revolves around potential inaccuracies in previously issued financial statements. Investors must be aware that the upcoming deadline to file a lead plaintiff...

Continue Reading
Newtopia Partners with Payvider for Enhanced Health Benefits

Updated Category News Views 278

Newtopia Partners with Payvider for Enhanced Health Benefits Newtopia Inc. (NEWU; NEWUF), a leader in tech-enabled habit change solutions, is thrilled to announce its new partnership with a supplemental insurance payvider. This exciting collaboration aims to provide Newtopia's successful habit change platform as a fully-covered benefit for thousands of workers in the...

Continue Reading
A4A Celebrates 250 Years of American Independence through Aviation

Updated Category News Views 94

A4A Launches Campaign for America's 250th Anniversary Airlines for America (A4A) is excited to unveil a memorable campaign, "Red, Flight & Blue—Celebrating America 250," which aims to celebrate the 250th anniversary of the United States. This significant campaign will utilize a variety of platforms, including social media, blog posts, and videos, to highlight the...

Continue Reading
Alexander’s Secures $400M Loan for New York Office Refinancing

Updated Category News Views 238

ALEXANDER’S, INC. concluded a hefty refinancing deal worth $400 million for its office condominium at 731 Lexington Avenue back in 2024. This isn’t just any property; it’s where Bloomberg LP hangs its hat—a landmark in the bustling New York City real estate scene. Traders were glued to this one because it wasn’t just about refinancing but about what it signals...

Continue Reading
IDV Secures Major Contract for Military Logistics Vehicles

Updated Category News Views 239

IDV Secures a Major Tender from the Dutch Armed Forces In a significant development for military logistics, IDV, part of the renowned Iveco Group (EXM: IVG), has successfully secured a contract with the Dutch Ministry of Defence. This contract entails supplying an impressive fleet of 785 military logistics vehicles, which includes three distinct versions: semitrailer...

Continue Reading